SCHEMBL15070488

SCHEMBL15070488

Cc1cccnc1C(=O)N1CCC(C)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.53
APOBEC3A P31941 1/20 0.52
APOBEC3G Q9HC16 1/20 0.52
ALDH1A1 P00352 2/20 0.51
TP53 P04637 1/20 0.51
HPGD P15428 1/20 0.51
PDE10A Q9Y233 1/20 0.51
KMT2A Q03164 2/20 0.48
CCR5 P51681 1/20 0.47
KCNH2 Q12809 1/20 0.47
PDE2A O00408 1/20 0.47
CTSB P07858 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
GRM5 P41594 2/20 0.45
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22840490 0.84 ACHE (0.51) ACHEAPOBEC3AAPOBEC3GALDH1A1TP53
SCHEMBL19002768 0.81 HCRTR1 (0.55) ACHEAPOBEC3AAPOBEC3GKMT2ACYP3A4
SCHEMBL4661842 0.81 PDE10A (0.49) PDE10A
SCHEMBL17206945 0.81 PDE10A (0.49) ALDH1A1HPGDPDE10A
SCHEMBL14818783 0.78 NPC1 (0.56) ALDH1A1TP53HPGDPDE10AKMT2A
SCHEMBL17546313 0.78 ACHE (0.57) ACHEAPOBEC3AAPOBEC3GALDH1A1TP53
SCHEMBL1810699 0.78 CNR1 (0.48) ALDH1A1KMT2AKCNH2
SCHEMBL6263224 0.77 GAA (0.50) HPGDPDE10AKMT2APDE2AGRM5
SCHEMBL14818746 0.76 PDE10A (0.48) ALDH1A1HPGDPDE10APDE2A
SCHEMBL22840303 0.76 APOBEC3A (0.55) ACHEAPOBEC3AAPOBEC3GALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181183-B2 Prostaglandin D synthase inhibitory piperidine compounds TAIHO PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
US-9181183-B2 Prostaglandin D synthase inhibitory piperidine compounds TAIHO PHARMACEUTICAL CO., LTD. (JP) 2015-11-10 US disclosed
US-20130165438-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2013-06-27 US disclosed
US-20130165438-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS TAIHO PHARMACEUTICAL CO., LTD. (JP) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165438-A1 PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS PTGIS, PTGS1, PTGDR ACHE 1060/4885APOBEC3A 2650/4885APOBEC3G 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.